By Dave Simpson ( October 12, 2017, 10:37 PM EDT) -- Allergan announced Thursday it has reached a deal with Pfizer-owned drugmaker InnoPharma to end litigation over patents protecting its dry-eye treatment Restasis, a month after Allergan transferred its Restasis patents to a Native American tribe in a bid to escape Patent Trial and Appeal Board review....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.